Gestational diabetes and hypoglycemia are more closely linked than most people realize. The condition itself is defined by blood sugar running too high during pregnancy, but the treatments used to bring those levels down can push blood sugar too low, sometimes dangerously so. Insulin therapy is the most common culprit, though the relationship between GDM management and low blood sugar episodes involves diet timing, hormonal shifts unique to pregnancy, and even what happens to the baby after delivery.
Why Blood Sugar Behaves Differently During Pregnancy
Even in a healthy pregnancy without diabetes, fasting blood sugar drops during the first trimester. Research from the Diabetes in Early Pregnancy Study found a measurable decline in fasting glucose between weeks six and ten, well before the fetus is large enough to be drawing significant energy from the mother’s bloodstream. That early dip appears to be driven by the mother’s own metabolic adjustments rather than fetal demand.1PubMed. Physiological reduction in fasting plasma glucose concentration in the first trimester of normal pregnancy: the diabetes in early pregnancy study
As pregnancy progresses, the placenta releases hormones like placental lactogen that actively promote insulin resistance. This is the body’s way of keeping extra glucose available for the growing fetus. Placental lactogen also stimulates the insulin-producing cells in the pancreas to multiply and ramp up output, trying to keep pace with rising demand.2PubMed Central. Placental Lactogen as a Marker of Maternal Obesity, Diabetes, and Fetal Growth Abnormalities: Current Knowledge and Clinical Perspectives When those pancreatic cells cannot compensate fast enough, blood sugar climbs and gestational diabetes develops.3PubMed. Placental peptides regulating islet adaptation to pregnancy: clinical potential in gestational diabetes mellitus
This tug-of-war between insulin resistance and insulin production creates an inherently unstable metabolic situation. Blood sugar can swing from too high after a meal to too low overnight, and any external insulin or medication layered on top of this already volatile system increases the odds of hypoglycemia.
How GDM Is Diagnosed
Screening for gestational diabetes typically happens between weeks 24 and 28 of pregnancy using an oral glucose tolerance test. Different medical bodies disagree on exactly how that test should be performed and what thresholds count as a diagnosis. Some guidelines call for a two-step process starting with a 50-gram glucose challenge, while others recommend going straight to a 75-gram glucose load and measuring blood sugar at fasting, one hour, and two hours afterward.4PubMed Central. Updated guidelines on screening for gestational diabetes The specific cutoff values vary too. International guidelines from organizations like the WHO and IADPSG set fasting thresholds and post-load values that differ from older criteria used in many countries.5PubMed Central. Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand
What matters for the hypoglycemia question is that diagnostic criteria have historically been based on the mother’s future diabetes risk or on statistical norms rather than on outcomes for the baby. Only in recent years have guidelines begun to anchor thresholds to actual pregnancy complications, after a landmark study showed that the relationship between a mother’s blood sugar and adverse outcomes is continuous with no obvious safe cutoff.6PubMed. Evolution of diagnostic criteria for gestational diabetes mellitus This means some women are treated aggressively who sit just above the line, and the tighter the target, the greater the chance of overcorrecting into hypoglycemia.
When Treatment Itself Causes Low Blood Sugar
Insulin is the gold-standard medication for GDM that cannot be controlled by diet alone, and insulin is also the treatment most likely to cause hypoglycemia. A study using continuous glucose monitors found nocturnal hypoglycemic episodes, with glucose dropping below 50 mg/dL, in 14 patients, all of whom were on insulin. Standard fingerstick testing missed these overnight lows entirely.7PubMed. Continuous glucose monitoring for the evaluation and improved control of gestational diabetes mellitus That finding matters because overnight lows can happen while you are asleep and completely unaware.
One reassuring finding is that the risk of hypoglycemia does not necessarily climb as the insulin dose goes up. Research looking at insulin-treated GDM found that incremental dose increases were not associated with a higher incidence of hypoglycemia.8American Journal of Obstetrics & Gynecology. Hypoglycemia in insulin-treated gestational diabetes: is it dose dependent? So if your care team is raising your dose, that alone does not mean you are headed for a dangerous low.
Oral medications carry different risk profiles. A meta-analysis comparing metformin, glyburide, and insulin found that women on metformin had a substantially lower rate of maternal hypoglycemia compared to those on insulin.9PubMed Central. Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis Metformin works by reducing the liver’s glucose output rather than directly pushing insulin levels higher, which is why it tends to cause fewer lows. Glyburide, on the other hand, stimulates the pancreas to release more insulin and can sometimes produce hypoglycemia through a mechanism similar to injected insulin.
Recognizing the Symptoms
The classic signs of hypoglycemia are sweating, shaking, a racing heartbeat, dizziness, confusion, and irritability. During pregnancy, some of these overlap with normal discomforts like fatigue or lightheadedness, which can make low blood sugar easy to dismiss.
A survey of pregnant women with diabetes found that only about one in five knew that sweating and shivering were signs of hypoglycemia. Even among women already diagnosed with GDM, roughly half could not identify these symptoms. The researchers flagged this as a serious gap because women who self-monitor blood sugar at home but do not recognize hypoglycemia symptoms are more likely to panic, lose confidence in their treatment, or stop using insulin altogether.10Medical Journal of Bakırköy. What is Gestational Diabetes Mellitus Awareness in Pregnant Women: A Survey Study
Mild hypoglycemia can usually be treated at home with fast-acting carbohydrates: a few glucose tablets, half a glass of juice, or a handful of candy. The standard advice is to eat about 15 grams of carbohydrates, wait 15 minutes, and recheck. Severe hypoglycemia, the kind that causes confusion or loss of consciousness, is rarer but does occur. In those cases, glucagon injections have been shown to reverse unconsciousness rapidly in pregnant women, with no apparent short- or long-term harm to the mother.11PubMed. Reversing severe hypoglycemia during pregnancy with glucagon therapy Guidelines for managing diabetes in pregnancy recommend that glucagon be available in the home and that family members or partners know how to use it.12JAMA. Management of Preexisting Diabetes in Pregnancy: A Review
What Happens to the Baby
This is where the story flips. While the mother’s hypoglycemia risk comes from treatment, the baby’s hypoglycemia risk comes from undertreatment or poor glucose control. When a pregnant woman’s blood sugar stays high, the fetus is exposed to that same excess glucose. The baby’s pancreas responds by producing extra insulin to handle the flood. After delivery, once the umbilical cord is clamped and the maternal glucose supply stops, the baby’s overactive pancreas keeps pumping out insulin, pulling blood sugar down sharply. This neonatal hypoglycemia can require admission to intensive care.13PubMed Central. Analysis of risk factors of neonatal hypoglycemia and its correlation with blood glucose control of gestational diabetes mellitus: A retrospective study
When researchers looked at women who experienced hypoglycemia during their glucose tolerance test rather than during treatment, the outlook was different. Those women did not show higher rates of preterm delivery, cesarean section, postpartum hemorrhage, or neonatal intensive care admission compared to women with normal glucose readings.14PubMed Central. Hypoglycemia in pregnancy: maternal characteristics and neonatal outcomes from oral glucose tolerance tests In other words, occasional maternal hypoglycemia, at least the kind picked up during a screening test, does not appear to directly harm the baby. The bigger concern is always the sustained high blood sugar that drives the fetal insulin overproduction cycle.
Eating to Avoid the Roller Coaster
Diet is the first line of defense against both hyperglycemia and hypoglycemia in GDM, and how you time and distribute your carbohydrates matters as much as total quantity. Morning blood sugar is particularly hard to control because of the “dawn phenomenon,” a natural rise in insulin resistance that peaks in the early hours. Refined cereals and white bread at breakfast can send glucose soaring, followed by a crash.
A practical approach recommended in clinical nutrition reviews is to split breakfast into two smaller meals eaten about two hours apart, with only about 10 to 20 percent of total daily carbohydrates consumed in the morning. Lunch and dinner each get about 30 percent, with two small snacks filling in the gaps. A high-protein bedtime snack helps prevent overnight ketosis and keeps blood sugar from dipping too low while you sleep.15Journal of Diabetology. Management of Gestational Diabetes Mellitus with Medical Nutrition Therapy: A Comprehensive Review
The general principle is to avoid large boluses of carbohydrates at any single sitting. Pairing carbohydrates with protein and fat slows digestion, blunts the glucose spike, and reduces the reactive dip that follows. Skipping meals is one of the most common triggers for hypoglycemia in GDM, especially among women on insulin, because the medication keeps working even when no food is coming in.
Exercise and Blood Sugar Stability
Physical activity improves insulin sensitivity, which helps keep blood sugar in range, but it can also lower glucose enough to cause problems if timing is not considered. Clinical guidelines recommend that women with GDM do both aerobic and resistance exercise at moderate intensity, at least three times a week for 30 to 60 minutes per session.16PubMed Central. Exercise guidelines for gestational diabetes mellitus Walking after meals is a common recommendation because it uses some of the glucose from the meal and smooths out the postprandial spike.
The practical risk is exercising on an empty stomach or stacking a workout on top of an insulin dose without eating. Checking blood sugar before and after exercise, and carrying a quick source of carbohydrates, is standard advice for women on insulin or glyburide. Women managing GDM with diet alone are at much lower risk of exercise-induced hypoglycemia but should still avoid long periods without food.
The Psychological Weight of Managing Both Ends
Managing GDM already transforms the experience of pregnancy. Research has documented that the diagnosis generates significant fear, depression, and anxiety, partly because many women associate diabetes with severe long-term complications like blindness and amputations, even though gestational diabetes often resolves after delivery.17Sociology of Health & Illness. A transformed pregnancy: the psychosocial consequences of gestational diabetes
Layering the threat of hypoglycemia on top of that creates a specific form of distress that researchers call fear of hypoglycemia. A study of diabetic pregnant women found that having a history of hypoglycemic episodes was the strongest predictor of this fear. Other risk factors included being on insulin, having lower education, younger age, and depression.18Primary Care Diabetes. Fear of hypoglycemia and its predictive factors among diabetic pregnant women The fear is not trivial. Women who are afraid of going low may deliberately keep their blood sugar higher than their target range, undermining the very treatment their care team has prescribed. Some reduce their insulin doses on their own or eat extra food they do not need, trading the risk of a low for the risk of running high, which can harm the baby.
Prevalence estimates of clinically significant fear of hypoglycemia vary widely depending on how it is measured. One study at a medical center in Saudi Arabia found that about one in ten diabetic pregnant women met the threshold for significant fear, though most participants had gestational rather than pre-existing diabetes.19PubMed Central. Prevalence and risk factors of fear of hypoglycemia (FOH) among diabetic pregnant women at King Abdulaziz Medical City- Jeddah (KAMC-J), Saudi Arabia The evidence suggests that normalizing conversations about hypoglycemia, teaching partners and family members to recognize the signs, and ensuring access to continuous glucose monitoring when possible all reduce this anxiety.
Myoinositol and Reducing the Need for Insulin
One way to lower the odds of hypoglycemia is to reduce the need for insulin in the first place. Myoinositol, a naturally occurring sugar alcohol found in fruits and beans, has shown promise here. A meta-analysis of randomized controlled trials found that myoinositol supplementation starting around the 12th to 13th week of pregnancy cut the risk of developing GDM by roughly 70 percent compared to placebo. Among women who did develop GDM, myoinositol significantly lowered fasting glucose and post-load glucose values, and reduced the number of women who needed insulin.20PubMed Central. Myoinositols Prevent Gestational Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis of Randomized Controlled Trials The same meta-analysis found that myoinositol reduced the risk of neonatal hypoglycemia as well.
A pilot trial in Asian Indian women with GDM reported that supplementing with 1 gram of myoinositol twice daily achieved glycemic control in about 90 percent of patients, compared to about 68 percent in the control group.21PubMed. Efficacy of myoinositol in treatment of gestational diabetes mellitus in Asian Indian women: A pilot randomized clinical trial Another study found that women treated with myoinositol needed less insulin in both the second and third trimesters and experienced fewer hypoglycemic episodes than those who were not supplemented.22PubMed Central. Myoinositol supplementation in the treatment of gestational diabetes mellitus: effects on glycaemic control and maternal-foetal outcomes
This does not mean myoinositol is a replacement for standard care. The research is encouraging but still consists of relatively small trials, and major obstetric guidelines have not yet incorporated it into routine recommendations. If you are interested, it is worth raising with your provider, especially if you are at high risk for GDM and looking for ways to minimize medication exposure.
Racial and Ethnic Disparities in GDM and Its Complications
The risk of developing gestational diabetes is not evenly distributed. A large study in the United States found that prevalence ranged from about 4 percent among non-Hispanic white and Black women to over 11 percent among Asian Indian women, with Filipina, Southeast Asian, and Chinese women also at elevated risk. Being born outside the United States increased the risk further for most groups, by roughly 80 percent among Asian Indian, Black, and Filipina women.23PubMed Central. Disparities in the risk of gestational diabetes by race-ethnicity and country of birth
Disparities do not stop at diagnosis. Among women with GDM, Black women had nearly 80 percent higher odds of neonatal hypoglycemia compared to other racial groups, along with higher odds of preeclampsia and preterm delivery.24PubMed Central. The effect of race/ethnicity on adverse perinatal outcomes among patients with gestational diabetes mellitus Part of the explanation may be structural. A study examining when women with GDM were started on medication found that Black and Hispanic women had a significantly higher percentage of elevated blood glucose readings before their providers initiated pharmacotherapy, compared to white women, even after adjusting for clinical factors.25PubMed Central. Maternal racial and ethnic disparities in glycemic threshold for pharmacotherapy initiation for gestational diabetes In plain terms, minority women had to be running higher for longer before they received medication, a delay that would increase both fetal glucose exposure and downstream neonatal hypoglycemia risk.
After Delivery and the Long View
Gestational diabetes usually resolves within hours of delivering the placenta, because the hormones driving insulin resistance disappear. At that point the immediate hypoglycemia concern shifts almost entirely to the baby, whose overtuned pancreas may take time to recalibrate. Mothers who were on insulin typically stop it right after delivery, though blood sugar should still be monitored for a few days to confirm levels have normalized.
The longer-term risk, though, is type 2 diabetes. A large cohort study found that a history of GDM increased the risk of developing type 2 diabetes nearly fourfold in the 6 to 15 years after an affected pregnancy, with risk climbing steeply if a woman had GDM in more than one pregnancy. The elevated risk persisted for more than 35 years, though it gradually decreased with each passing decade.26PubMed Central. Persistence of Risk for Type 2 Diabetes After Gestational Diabetes Mellitus A separate meta-analysis estimated the pooled risk at roughly nine times higher for women with a history of GDM compared to those without.27PubMed Central. Risk of type 2 diabetes mellitus after gestational diabetes mellitus: A systematic review & meta-analysis
One protective factor that has emerged from the research is breastfeeding. A prospective cohort study followed over a thousand women without diabetes at baseline and found graded reductions in the risk of developing type 2 diabetes with increasing breastfeeding intensity and duration. Women who breastfed exclusively for more than ten months had less than half the risk compared to those who breastfed for two months or less.28PubMed Central. Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus: A Prospective Cohort Study The mechanism is not fully understood, but lactation appears to improve insulin sensitivity and help the body reset its glucose metabolism after the metabolic upheaval of pregnancy.
Postpartum glucose screening, usually recommended at six to twelve weeks after delivery, is important but widely underused. Many women feel healthy, assume the problem is behind them, and skip the follow-up test. Given how steep the long-term risk curve is, that screening is one of the most actionable things a woman with a history of GDM can do for her future health.